Notably, no direct physical interaction between FATP5 and AMPK or mTOR was observed in HCC cells, supporting that FATP5 may indirectly activate the AMPK/mTOR pathway by manipulating cellular glycolysis and energy production. Here, MTOR is linked to hepatocellular carcinoma.